|
|
|
市場調查報告書
髂骨動脈瘤:全球臨床實驗檢討
Iliac Aneurysms Global Clinical Trials Review, H1, 2012
| 出版商 |
GlobalData |
| 出版日期 |
2012年01月 |
商品編碼 |
226836 |
| 內容資訊 |
英文 Pages: 43 |
| 價格 |
|
|
髂骨動脈瘤:全球臨床實驗檢討 是由出版商GlobalData在2012年01月所出版的。
這份英文市場調查報告書包含Pages: 43 價格從美金1000起跳。
目錄 目錄
- 表格一覽
- 圖表一覽
- 簡介
- 髂骨動脈瘤
- 報告指南
- 臨床實驗 各地區
- 臨床實驗 各國
- 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
- 對臨床實驗有所貢獻的前五國 - 歐洲
- 對臨床實驗有所貢獻的前幾名國家 - 北美
- 臨床實驗 ; 金磚四國 各國
- 臨床實驗 ; G7 各國
- 臨床實驗 - G7 各國 各臨床實驗狀態
- 臨床實驗 ; E7 各國
- 臨床實驗 - E7 各國 各臨床實驗狀態
- 臨床實驗 各臨床實驗狀態
- 未完成的臨床實驗; 髂骨動脈瘤
- 每段時期的實驗人數
- 有力的贊助商
- 前幾名參與企業 - 髂骨動脈瘤 治療藥物的臨床實驗
- 臨床實驗簡介
- 臨床實驗概要; 前幾名企業
- Cook
- 臨床實驗概要; Cook
- Boston Scientific Corporation
- 臨床實驗概要; Boston Scientific Corporation
- 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
- Maxima Medical Center
- 臨床實驗概要; Maxima Medical Center
- 5件重要臨床簡介
附錄
- 簡稱
- 定義
- 調查方法
- 二級研究
- 關於GlobalData
- 諮詢方式
- 免責聲明
- 資訊來源
表格一覽
- 髂骨動脈瘤 全球治療藥物市場, 臨床實驗 各地區
- 髂骨動脈瘤 全球治療藥物市場, 臨床實驗 各國排名
- 髂骨動脈瘤 全球治療藥物市場, 進行中的臨床實驗 各國排名
- 髂骨動脈瘤 治療藥物的臨床實驗, 亞太地區, 前幾名國家
- 髂骨動脈瘤 治療藥物的臨床實驗, 歐洲, 前五國
- 髂骨動脈瘤 治療藥物的臨床實驗, 北美, 前幾名國家
- 髂骨動脈瘤 治療藥物的臨床實驗, 金磚四國 各國
- 髂骨動脈瘤 治療藥物的臨床實驗, G7 各國
- 髂骨動脈瘤 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
- 髂骨動脈瘤 治療藥物的臨床實驗, E7 各國
- 髂骨動脈瘤 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
- 髂骨動脈瘤 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
- 髂骨動脈瘤 全球治療藥物市場, 終止的臨床實驗
- 髂骨動脈瘤 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
- 髂骨動脈瘤 全球治療藥物臨床實驗, 主要的贊助商
- 髂骨動脈瘤 全球治療藥物臨床實驗, 前幾名企業 各階段
- 髂骨動脈瘤 全球治療藥物臨床實驗市場, 臨床實驗 ; Cook
- 髂骨動脈瘤 全球治療藥物臨床實驗市場, 臨床實驗 ; Boston Scientific Corporation
- 髂骨動脈瘤 全球治療藥物臨床實驗市場, 臨床實驗 ; Maxima Medical Center
圖表一覽
- 髂骨動脈瘤 全球治療藥物市場, 臨床實驗 各地區 (%)
- 髂骨動脈瘤 全球治療藥物市場, 臨床實驗 各國排名
- 髂骨動脈瘤 全球治療藥物市場, 進行中的臨床實驗 各國排名
- 髂骨動脈瘤 治療藥物的臨床實驗, 亞太地區, 前幾名國家 (%)
- 髂骨動脈瘤 治療藥物的臨床實驗, 歐洲, 前五國 (%)
- 髂骨動脈瘤 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
- 髂骨動脈瘤 治療藥物的臨床實驗, 金磚四國 各國 (%)
- 髂骨動脈瘤 治療藥物的臨床實驗, G7 各國 (%)
- 髂骨動脈瘤 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
- 髂骨動脈瘤 治療藥物的臨床實驗, E7 各國 (%)
- 髂骨動脈瘤 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
- 髂骨動脈瘤 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
- 髂骨動脈瘤 全球治療藥物臨床實驗, 主要的贊助商
- 髂骨動脈瘤 全球治療藥物臨床實驗, 前幾名企業 各階段
- GlobalData 調查方法
Abstract
Summary
GlobalData's clinical trial report, "Iliac Aneurysms Global Clinical Trials Review, H2, 2011" provides data on the Iliac Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Iliac Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Iliac Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
- Table of Contents
- List of Tables
- List of Figures
- Introduction
- Iliac Aneurysms
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Trial Status
- Unaccomplished Trials of Iliac Aneurysms
- Subjects Recruited Over a Period of Time
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Cook
- Clinical Trial Overview of Cook
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Maxima Medical Center
- Clinical Trial Overview of Maxima Medical Center
- Five Key Clinical Profiles
Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
List of Tables
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, BRIC Countries, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, G7 Countries, 2012*
- Iliac Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, E7 Countries, 2012*
- Iliac Aneurysms Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Iliac Aneurysms Therapeutics Market, Global, Terminated Clinical Trials, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Iliac Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Cook, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Maxima Medical Center, 2012*
List of Figures
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, BRIC Countries (%), 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Iliac Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, E7 Countries (%), 2012*
- Iliac Aneurysms Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
- Iliac Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Iliac Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Iliac Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- GlobalData Methodology
|
 |
